Game Creek Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,000
Closed -$2.15M 103
2025
Q4
$2.15M Buy
+2,000
New +$1.91M 0.71% 50

Other funds holding LLY

Game Creek Capital's LLY Position: Q1 2026 in Review

Game Creek Capital reduced its Eli Lilly (LLY) stake by 1.9% in Q1 2026, selling an estimated $127K and leaving 6,625 shares worth $6.09M. The position accounts for 2.03% of the portfolio, ranked #13.

Game Creek Capital first reported a position in LLY in Q4 2017 and has held it in 5 quarters since. The position peaked at $7.25M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Game Creek Capital held 6,625 shares of Eli Lilly worth $6.09M as of Q1 2026.
  • Game Creek Capital sold 125 Eli Lilly shares in Q1 2026, an estimated $127K.
  • Eli Lilly made up 2.03% of Game Creek Capital's portfolio in Q1 2026, its #13 holding.
  • Game Creek Capital first reported a position in Eli Lilly in Q4 2017 and has held it in 5 quarters since.
  • Game Creek Capital's Eli Lilly position peaked at $7.25M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Game Creek Capital's 13F filing for Q1 2026, filed 14 May 2026.